In fiscal year 2018, the leading product in terms of sales of the Japanese pharmaceutical company Takeda Pharmaceutical Co. was Entyvio, with a sales value of more than 269 billion Japanese yen. Entyvio is a prescription drug treating adult patients with ulcerative colitis and Crohn's disease.
Global major products' sales revenue of Takeda Pharmaceutical Co., Ltd. in fiscal year 2018
(in billion Japanese yen)
fiscal year 2018; the company’s fiscal year starts on April 1 of the stated year and ends on March 31 of the following year
Supplementary notes
1 Japanese yen equals 0.00943 U.S. dollars or 0.00862 euros as of September 2019.
The source does not provide an exact publication date. Date given here is the day of data access.
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
Statista Accounts:
Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
Instant access to 1m statistics
Download in XLS, PDF & PNG format
Detailed references
$59 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Statista Accounts:
Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.
Takeda Pharmaceutical Company. (September 23, 2019). Global major products' sales revenue of Takeda Pharmaceutical Co., Ltd. in fiscal year 2018 (in billion Japanese yen) [Graph]. In Statista. Retrieved February 22, 2020, from https://www.statista.com/statistics/878059/takeda-pharmaceutical-global-major-products-sales/
Takeda Pharmaceutical Company. "Global major products' sales revenue of Takeda Pharmaceutical Co., Ltd. in fiscal year 2018 (in billion Japanese yen)." Chart. September 23, 2019. Statista. Accessed February 22, 2020. https://www.statista.com/statistics/878059/takeda-pharmaceutical-global-major-products-sales/
Takeda Pharmaceutical Company. (2019). Global major products' sales revenue of Takeda Pharmaceutical Co., Ltd. in fiscal year 2018 (in billion Japanese yen). Statista. Statista Inc.. Accessed: February 22, 2020. https://www.statista.com/statistics/878059/takeda-pharmaceutical-global-major-products-sales/
Takeda Pharmaceutical Company. "Global Major Products' Sales Revenue of Takeda Pharmaceutical Co., Ltd. in Fiscal Year 2018 (in Billion Japanese Yen)." Statista, Statista Inc., 23 Sep 2019, https://www.statista.com/statistics/878059/takeda-pharmaceutical-global-major-products-sales/
Takeda Pharmaceutical Company, Global major products' sales revenue of Takeda Pharmaceutical Co., Ltd. in fiscal year 2018 (in billion Japanese yen) Statista, https://www.statista.com/statistics/878059/takeda-pharmaceutical-global-major-products-sales/ (last visited February 22, 2020)
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.
